[R01] Neuroprotective Strategy: Novel Purine Derivatives for Neonatal Hypoxia-ischemia

Ente: National Institute of Neurological Disorders and Stroke

Scadenza: 2027-01-31

Importo max: $337,718

Paese: US

Descrizione

PROJECT SUMMARY/ABSTRACT Hypoxia-ischemia (HI) is the one of leading causes of neurodevelopmental morbidities in preterm and full-term infants. The only therapeutic strategy to treat HI encephalopathy (HIE) in full term infants is hypothermia, which is only partially protective. The only therapy for

Settori: National Institute of Neurological Disorders and Stroke

Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.